Tierney Saccavino | Investor Relations |
Ron Cohen | President and Chief Executive Officer |
Michael Gesser | Chief Financial Officer |
Raghuram Selvaraju | H.C. Wainwright |
Welcome to Acorda Therapeutics’ Third Quarter 2022 Financial and Business Update. At his time, all participants are in a listen-only mode. There will be a question and answer session to follow. Please be advised that this call is being recorded at the Company’s request. I will now introduce your host for today’s call, Tierney Saccavino at Acorda.